Navigation

Electronic clinical audit tools

Between June 2011 and August 2012 NICE produced Electronic clinical audit tools, which were Excel versions of Word based Clinical audit tools. Both versions are tools for local clinical audit to improve care, containing clinical audit standards based on NICE guidance.

Access the Electronic clinical audit tools from the table below.

Excel based tools are still produced but can now be found our Clinical audit page, with all other tools to assist with local clinical audit.

Tell us what you think

We want to hear what you think of our clinical audit tools and your experiences of using them.

Details of some of the work we have already done to improve our audit tools can be found in the NICE clinical audit survey report 2011.

External Reference Group

If you are a clinical audit specialist or healthcare professional who would be prepared to help us review the clinical audit tools, please apply to join our Audit Panel.

Results 1-20 of 37

Ref Title Setting
CG50 Acutely ill patients in hospital: electronic audit tool General
CG115 Alcohol dependence and harmful alcohol use: electronic audit tool General
TA217 Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine: electronic tool General
CG134 Anaphylaxis: electronic audit tool General
CG149 Antibiotics for early-onset neonatal infection: electronic audit tool General
TA238 Arthritis (juvenile idiopathic, systemic) - tocilizumab: electronic audit tool General
TA249 Atrial fibrillation - dabigatran etexilate: electronic audit tool General
CG132 Caesarean section: electronic audit tool General
CG108 Chronic heart failure: electronic audit tool General
CG131 Colorectal cancer: electronic audit tools General
TA176 Colorectal cancer (first line) - cetuximab: biological agents for metastatic colorectal cancer - electronic audit tool General
TA242 Colorectal cancer (metastatic) 2nd line - cetuximab, bevacizumab and panitumumab (review): biological agents for metastatic colorectal cancer - electronic audit tool General
TA212 Colorectal cancer (metastatic) - bevacizumab: biological agents for metastatic colorectal cancer - electronic audit tool General
TA118 Colorectal cancer (metastatic) - bevacizumab and cetuximab: biological agents for metastatic colorectal cancer - electronic audit tool General
TA61 Colorectal cancer - capecitabine and tegafur uracil: chemotherapy for advanced and metastatic colorectal cancer - electronic audit tool General
TA211 Constipation (women) - prucalopride: electronic audit tool General
DG5 DG5 SonoVue (sulphur hexafluoride microbubbles) - contrast agent for contrast-enhanced ultrasound imaging of the liver: electronic audit tool General
IPG390 Endovascular stent-grafting of popliteal aneurysms: electronic audit tool General
CG71 Familial hypercholesterolaemia: electronic audit tool General
CG87 GLP-1 agonists for the treatment of type 2 diabetes: electronic audit tool General

This page was last updated: 23 April 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.